Eurasian Search Report for Application No. 200000578/28, for application filed Jun. 26, 2000. |
WPINDEX, Accession No. 1993-218199, Derwent WPI English language abstract for SU 174261. |
WPINDEX, Accession No. 1978-L1249A, Derwent WPI English language abstract for SU 328634. |
Caplus abstract Semple Edward et al Journal of Medicinal Chemistry 1996.* |
Barrett, A.J., “Proteinase inhibitors: potential drugs?” in Enzyme Inhibitors as Drugs, Sandler, M., ed., The Macmillan Press Ltd., London, England, pp. 219-229 (1980). |
Brown, F. J. et al., “Design of Orally Active, Non-Peptidic Inhibitors of Human Leukocyte Elastase,” J. Med. Chem. 37:1259-1261, American Chemical Society (1994). |
Claeson, G., “Synthetic peptides and peptidomimetics as substrates and inhibitors of thrombin and other proteases in the blood coagulation system,” Blood Coagulation and Fibrinolysis 5:411-436, Rapid Communications (1994). |
Coughlin, S. R., “Molecular Mechanisms of Thrombin Signaling,” Seminars in Hematology 31:270-277, W.B. Saunders Company (1994). |
Cuypers, H. T. et al., “Sulfhydryl Content of Bovine Eye Lens Leucine Aminopeptidase. Determination of the reactivity of the sulfhydryl groups of the zinc metalloenzyme, of the enzyme activated by Mg2+, Mn2+, and Co2+, and of the metal-free apoenzyme,” J. Biol. Chem. 257:7086-7091, American Society of Biological Chemists, Inc. (1982). |
de Roos, A. et al., “Myocardial infarct sizing and assessment of reperfusion by magnetic resonance imaging: a review,” Int. J. Cardiac Imaging 7:133-138, Kluwer Academic Publishers (1991). |
Edwards, P. D. et al., “Design, Synthesis, and Kinetic Evaluation of a Unique Class of Elastase Inhibitors, the Peptidyl α-Ketobenzoxazoles, and the X-ray Crystal Structure of the Covalent Complex between Porcine Pancreatic Elastase and Ac-Ala-Pro-Val-2-Benzoxazole,” J. Am. Chem. Soc. 114:1854-1863, American Chemical Society (1992). |
Harker, L. A., “Strategies for inhibiting the effects of thrombin,” Blood Coagulation and Fibrinolysis 5:S47-S58, Rapid Communications (1994). |
Jeong, J.-H. et al., “Cyclic Guanidino-Sugars with Low pKa as Transition-State Analog Inhibitors of Glycosidases: Neutral Instead of Charged Species Are the Active Forms,” J. Am. Chem. Soc. 118:4227-4234, American Chemical Society (1996). |
Kim, K. S. et al., “Preparation of Argatroban Analog Thrombin Inhibitors with Reduced Basic Guanidine Moiety, And Studies of Their Cell Permeability and Antithrombotic Activities,” Med. Chem. Res. 6:377-383, Birkhäuser Boston (1996). |
Lefkovits, J., and Topol, E. J., “Direct Thrombin Inhibitors in Cardiovascular Medicine,” Circulation 90:1522-1536, American Heart Association, Inc. (1994). |
Mack, H. et al., “Design, Synthesis and Biological Activity of Novel Rigid Amidino-Phenylalanine Derivatives as Inhibitors of Thrombin,” J. Enzyme Inhibition 9:73-86, Harwood Academic Publishers GmbH (1995). |
Powers, W. J. et al., “Indium-111 platelet scintigraphy in cerebrovascular disease,” Neurology 32:938-943, American Academy of Neurology (1982). |
Saulnier, M. G. et al., “An Efficient Method for the Synthesis of Guanidino Prodrugs,” Bioorg. Med. Chem. Lett. 4:1985-1990, Elsevier Science Ltd (1994). |
Thakur, M. L. et al., “Indium-111 Labeled Platelets: Studies on Preparation and Evaluation of In Vitro and In Vivo Functions,” Thrombosis Res. 9:345-357, Pergamon Press, Inc. (1976). |
CAPLUS 127:234621, abstract of Lee, S.-1. et al., “Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes,” Accession No. 1997: 594514 (1997). |